Targeting ferritin receptors for the selective delivery of imaging and therapeutic agents to breast cancer cells
-
- S. Geninatti Crich
- University of Turin
-
- M. Cadenazzi
- University of Turin
-
- S. Lanzardo
- University of Turin
-
- L. Conti
- University of Turin
-
- R. Ruiu
- University of Turin
-
- D. Alberti
- University of Turin
-
- F. Cavallo
- University of Turin
-
- J. C. Cutrin
- University of Turin
-
- S. Aime
- University of Turin
書誌事項
- 公開日
- 2015
- DOI
-
- 10.1039/c5nr00352k
- 公開者
- Royal Society of Chemistry (RSC)
この論文をさがす
説明
<p>Horse Spleen Apoferritin has been exploited to deliver simultaneously therapeutic and imaging agents to breast cancer cells <italic>via</italic> the ferritin transporting route. The selective uptake has been investigated by MRI, and exploited for the simultaneous delivery of Curcumin, a compound with strong anti-neoplastic and anti-inflammatory action.</p>
収録刊行物
-
- Nanoscale
-
Nanoscale 7 (15), 6527-6533, 2015
Royal Society of Chemistry (RSC)